Literature DB >> 1848253

Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells.

H Kato1, H Suzuki, S Tajima, Y Ogata, T Tominaga, A Sato, T Saruta.   

Abstract

The aim of the present study was to investigate whether angiotensin II, by increasing extracellular matrix synthesis, contributed to the vascular wall thickening observed in hypertension. Thus, we examined the direct effects of angiotensin II on collagen and fibronectin synthesis in cultured rat vascular smooth muscle cells by measuring 3H-proline incorporation. Angiotensin II, in a concentration of 10 mumol/l, increased collagen synthesis in a dose-dependent manner up to 1.8-fold. This increase occurred within 24 h after the addition of angiotensin II and the time required to reach maximum stimulation was approximately 48 h. This increase was receptor-mediated and correlated with an increase in its specific messenger RNA. A closer study of the collagen increase demonstrated a relatively greater increase in type V collagen than type I or type III collagen. Fibronectin synthesis was also increased 1.5-fold with 10 mumol/l angiotensin II. These data suggest that angiotensin II induces vascular wall thickening by acting directly on smooth muscle cells and enhancing the production of extracellular matrix proteins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848253

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  38 in total

Review 1.  Local renin-angiotensin systems in the genitourinary tract.

Authors:  Craig Comiter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-11-13       Impact factor: 3.000

Review 2.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

3.  The role of the neurohormonal system in heart failure.

Authors:  M Komajda; F Pousset; R Isnard; P Lechat
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

4.  Mechanisms of Metabolic Acidosis-Induced Kidney Injury in Chronic Kidney Disease.

Authors:  Donald E Wesson; Jerry M Buysse; David A Bushinsky
Journal:  J Am Soc Nephrol       Date:  2020-01-27       Impact factor: 10.121

Review 5.  Future Treatment of Hypertension: Shifting the Focus from Blood Pressure Lowering to Arterial Stiffness Modulation?

Authors:  Henry Fok; J Kennedy Cruickshank
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

Review 6.  Genetic determinants of arterial stiffness.

Authors:  Jeongok G Logan; Mary B Engler; Hyungsuk Kim
Journal:  J Cardiovasc Transl Res       Date:  2014-12-04       Impact factor: 4.132

7.  Replacement of salt by a novel potassium- and magnesium-enriched salt alternative improves the cardiovascular effects of ramipril.

Authors:  E M Mervaala; I Paakkari; J Laakso; R Nevala; T M Teräväinen; F Fyhrquist; H Vapaatalo; H Karppanen
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

Review 8.  Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies.

Authors:  John W Wright; Shigehiko Mizutani; Joseph W Harding
Journal:  Heart Fail Rev       Date:  2007-11-07       Impact factor: 4.214

9.  Angiotensin II induces a region-specific hyperplasia of the ascending aorta through regulation of inhibitor of differentiation 3.

Authors:  A Phillip Owens; Venkateswaran Subramanian; Jessica J Moorleghen; Zhenheng Guo; Coleen A McNamara; Lisa A Cassis; Alan Daugherty
Journal:  Circ Res       Date:  2009-12-17       Impact factor: 17.367

10.  Orphan nuclear receptor small heterodimer partner inhibits angiotensin II- stimulated PAI-1 expression in vascular smooth muscle cells.

Authors:  Kyeong-Min Lee; Hye-Young Seo; Mi-Kyung Kim; Ae-Kyung Min; Seong-Yeol Ryu; Yoon-Nyun Kim; Young Joo Park; Hueng-Sik Choi; Ki-Up Lee; Wan-Ju Park; Keun-Gyu Park; In-Kyu Lee
Journal:  Exp Mol Med       Date:  2010-01-31       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.